WebMD8h
New Guidance for Patients Taking GLP-1 Drugs Before Surgery
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.
CBS19 News9h
Virginia Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Jackson Progress-Argus10h
Georgia Has the 5th Highest Rate of GLP-1 Use in the Nation
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
The Manhattan Mercury12h
Kansas Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Southwest Iowa News12h
Iowa Has the 9th Highest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Hastings Tribune12h
Nebraska Residents Are Using GLP-1s at a Slightly Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Stoneham Independent13h
Massachusetts Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Grainger County13h
Tennessee Residents Are Using GLP-1s at the 13th Highest Rate in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
The Caledonian Record13h
Vermont Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Fort Bend Herald13h
Texas Has the 10th Lowest Rate of GLP-1 Use in the Nation
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...